secwatch.observer — SEC 8-K summary
======================================

Issuer:     MiNK Therapeutics, Inc. (INKT)
CIK:        0001840229
Form:       8-K
Filed at:   2025-01-21T23:59:59+00:00
Accession:  0001193125-25-009595
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MiNK Therapeutics stockholders approve 1-for-10 reverse stock split effective Jan 28
--------------------------------------------------------------------------------

- Special meeting held Jan 17, 2025; 27,582,512 shares voted (quorum).
- Proposal approved with 26,500,274 For, 1,026,255 Against, 56,013 Abstain.
- Reverse split ratio 1-for-10, effective 12:01 a.m. ET on Jan 28, 2025.
- Post-split shares trade under new CUSIP 603693 201 on Nasdaq.
- 39,630,402 shares outstanding pre-split as of record date Dec 16, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840229/000119312525009595/0001193125-25-009595-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840229/000119312525009595/d926991d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-009595

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer